565.2K
XNYS Volume
High volume+loss today
XNYS 20 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Keith B. Johns | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2024 | 326,086 | 326,086 | - | 0 | Common Stock | |
| Ojas Buch | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2024 | 306,749 | 306,749 | - | 0 | Common Stock | |
| Ojas Buch | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 306,749 | 306,749 | - | - | Stock Option (Right to Buy) | |
| Shantanu Gaur | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 1,428,571 | 1,428,571 | - | - | Stock Option (Right to Buy) | |
| Shantanu Gaur | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 1,298,701 | 1,298,701 | - | - | Stock Option (Right to Buy) | |
| Ram Chuttani | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 May 2024 | 204,082 | 204,082 | - | - | Stock Option (Right to Buy) | |
| Alberti-Perez Milena | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 75,000 | 75,000 | - | 0 | Common Stock | |
| Chardon Benoit Jacques Claude | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.17 per share. | 12 Dec 2023 | 23,939 | 155,382 | - | 1.2 | 28,009 | Common Stock |
| Jacques Claude Chardon Benoit | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2023 | 18,741 | 20,377 | - | - | Stock Option (Right to Buy) | |
| Jacques Claude Chardon Benoit | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2023 | 97,799 | 0 | - | - | Stock Option (Right to Buy) | |
| Benoit Jacques Claude Chardon | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2023 | 23,939 | 510 | - | - | Stock Option (Right to Buy) | |
| Benoit Jacques Claude Chardon | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.88 per share. | 12 Dec 2023 | 18,741 | 199,183 | - | 1.9 | 35,233 | Common Stock |
| Jacques Claude Chardon Benoit | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.13 per share. | 12 Dec 2023 | 97,799 | 131,443 | - | 1.1 | 110,513 | Common Stock |
| Chardon Benoit Jacques Claude | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.95 per share. | 12 Dec 2023 | 25,060 | 180,442 | - | 1.0 | 23,807 | Common Stock |
| Chardon Jacques Claude Benoit | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2023 | 25,060 | 4,279 | - | - | Stock Option (Right to Buy) | |
| Omar Ishrak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2023 | 45,235 | 45,235 | - | 0 | Common Stock | |
| Douglas Larson Hudson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2023 | 45,235 | 45,235 | - | 0 | Common Stock | |
| Krishna K. Gupta | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2023 | 45,235 | 1,381,107 | - | 0 | Common Stock |